Dr. De Sutter Thomas
ActiveSummary
Dr. De Sutter Thomas has been active since 2019 and the Belgian State Gazette contains no insolvency or warning signals. The 2026 annual accounts show equity of €6k and a net result of €285k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 15% of 112 sector peers (fiscal year 2026). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2026
Axes · tick = 2025
Profitability100=
Solvency27=
Growth58=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit check for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2026Solvency, return and age of the figures
Solvency
1.7%
Return on assets
79%
Age of the figures
6 mo
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 15% of 112 sector peers (2026).
NBB · sector comparisonPosition among 112 sector peers
Solvency
better than 15%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-03-2026 was due by 31-10-2026 and was filed on 09-06-2026, 144 days ahead of the deadline.
NBB · 7 filingsDeviation from the deadline
2026
144 d early
2025
67 d early
2024
34 d early
2023
61 d early
2022
24 d early
2021
33 d early
2020
24 d early
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-03-2027 and is due by 31-10-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
25-09-2026 today31-03-2027 close31-10-2027 deadline
Financials · fiscal year 2026, micro schema
Equity
€6k=
2025 · €6k
2020: €46k
2021: €123k▲ +170% vs 2020
2022: €326k▲ +164% vs 2021highest in 7 years
2023: €106k▼ -67.4% vs 2022
2024: €6k▼ -94.3% vs 2023lowest in 7 years
2025: €6k● 0.0% vs 2024lowest in 7 years
2026: €6k● 0.0% vs 2025lowest in 7 years
2020 → 2026
Total assets
€360k▲ 4.1%
2025 · €346k
2020: €89klowest in 7 years
2021: €167k▲ +87.0% vs 2020
2022: €391k▲ +135% vs 2021
2023: €634k▲ +62.2% vs 2022highest in 7 years
2024: €406k▼ -36.0% vs 2023
2025: €346k▼ -14.7% vs 2024
2026: €360k▲ +4.1% vs 2025
2020 → 2026
Net result
€285k▼ 1.2%
2025 · €288k
2020: €40klowest in 7 years
2021: €78k▲ +95.7% vs 2020
2022: €202k▲ +161% vs 2021
2023: €259k▲ +27.8% vs 2022
2024: €321k▲ +24.2% vs 2023highest in 7 years
2025: €288k▼ -10.3% vs 2024
2026: €285k▼ -1.2% vs 2025
2020 → 2026
Working capital
€-68k▼ 631%
2025 · €-9k
2020: €32k
2021: €121k▲ +281% vs 2020
2022: €333k▲ +175% vs 2021highest in 7 years
2023: €88k▼ -73.7% vs 2022
2024: €-11k▼ -112% vs 2023
2025: €-9k▲ +12.3% vs 2024
2026: €-68k▼ -631% vs 2025lowest in 7 years
2020 → 2026
Trend over the years
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20222023202420252026Trend
Equity€326k-€106k▼ 67.4%€6k▼ 94.3%€6k=€6k=
2022: €326khighest in 5 years
2023: €106k▼ -67.4% vs 2022
2024: €6k▼ -94.3% vs 2023lowest in 5 years
2025: €6k● 0.0% vs 2024lowest in 5 years
2026: €6k● 0.0% vs 2025lowest in 5 years
Operating result€267k-€347k▲ 30.2%€423k▲ 21.7%€382k▼ 9.7%€378k▼ 1.1%
2022: €267klowest in 5 years
2023: €347k▲ +30.2% vs 2022
2024: €423k▲ +21.7% vs 2023highest in 5 years
2025: €382k▼ -9.7% vs 2024
2026: €378k▼ -1.1% vs 2025
Net result€202k-€259k▲ 27.8%€321k▲ 24.2%€288k▼ 10.3%€285k▼ 1.2%
2022: €202klowest in 5 years
2023: €259k▲ +27.8% vs 2022
2024: €321k▲ +24.2% vs 2023highest in 5 years
2025: €288k▼ -10.3% vs 2024
2026: €285k▼ -1.2% vs 2025
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has fallen two years in a row; 2026 is 1% below 2025.
Balance-sheet composition
2026 in colour, 2025 as the grey bar beneath
Assets €360k
Fixed assets
€89k ▲ 191%
Current assets
€271k ▼ 14.2%
Equity and liabilities €360k
Equity
€6k =
Debt
€354k ▲ 4.1%
Debt's share of the balance-sheet total rises from 98.3% to 98.3%. Debt is higher.
Key figures and ratios
EBITDA
€394k▼
2025 · €397k
Cash flow
€301k▼
2025 · €303k
Current ratio
0.80▼
2025 · 0.97
Debt to equity
59.05▲
2025 · 56.71
ROA
79.0%▼
2025 · 83.2%
Interest coverage
611.06▲
2025 · 565.59
Debt ≤ 1 year
€339k▲
2025 · €325k
Debt > 1 year
€1k▼
2025 · €15k
Income taxes
€92k▼
2025 · €93k
Staff costs
€8k▲
2025 · €5k
A ratio outside any meaningful range has been withheld (balance sheet total €360k, equity €6k).
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2026 against 2025 · 45 lines
Balance sheet
Code20252026
Assets
Total assets20/58€346k€360k▲
Fixed assets21/28€31k€89k▲
Tangible fixed assets22/27€31k€89k▲
Land and buildings22-€73k
Furniture and vehicles24€28k€14k▼
Other tangible fixed assets26€3k€2k▼
Current assets29/58€316k€271k▼
Amounts receivable within one year40/41€0€9k▲
Other amounts receivable41€0€9k▲
Cash at bank and in hand54/58€148k€68k▼
Deferred charges and accrued income490/1€168k€193k▲
Equity and liabilities
Total equity and liabilities10/49€346k€360k▲
Equity10/15€6k€6k=
Contributions10/11€6k€6k=
Profit (loss) carried forward14€0€0=
Amounts payable17/49€340k€354k▲
Amounts payable after more than one year17€15k€1k▼
Financial debts170/4€15k€1k▼
Amounts payable within one year42/48€325k€339k▲
Current portion of amounts payable after more than one year42€14k€14k▲
Financial debts43€0-
Credit institutions430/8€0-
Trade debts44€2k€26k▲
Suppliers440/4€2k€26k▲
Taxes, remuneration and social security45€15k€15k▼
Taxes450/3€15k€15k▼
Other amounts payable47/48€294k€285k▼
Accrued charges and deferred income492/3-€14k
Income statement
Code20252026
Remuneration, social security and pensions62€5k€8k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€15k€16k▲
Other operating charges640/8€4k€1k▼
Gross operating margin9900€406k€403k▼
Operating profit (loss)9901€382k€378k▼
Financial income75/76B€0€91▲
Recurring financial income75€0€91▲
Financial charges65/66B€702€644▼
Recurring financial charges65€702€644▼
Profit (loss) for the period before taxes9903€381k€377k▼
Income taxes67/77€93k€92k▼
Profit (loss) for the period9904€288k€285k▼
Profit (loss) for the period to be appropriated9905€288k€285k▼
Appropriation of the result
Profit (loss) to be appropriated9906€288k€285k▼
Transfer from equity791/2€0-
Profit to be distributed694/7€288k€285k▼
Return on contributions (dividend)694€288k€285k▼
The notes to these accounts (11 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Accounts by statement
| Line | 2022 | 2023 | 2024 | 2025 | 2026 | Change |
|---|---|---|---|---|---|---|
| Remuneration, social security and pensions62 | - | €4k | €4k | €5k | €8k | ▲ 77.6% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €9k | €20k | €15k | €15k | €16k | ▲ 5.9% |
| Other operating charges640/8 | €731 | €992 | €1k | €4k | €1k | ▼ 71.0% |
| Gross operating margin9900 | €276k | €373k | €443k | €406k | €403k | ▼ 0.6% |
| Operating profit (loss)9901 | €267k | €347k | €423k | €382k | €378k | ▼ 1.1% |
| Financial income75/76B | €0 | €119 | €3k | €0 | €91 | ▲ 23,963% |
| Recurring financial income75 | €0 | €119 | €3k | €0 | €91 | ▲ 23,963% |
| Financial charges65/66B | €2k | €4k | €1k | €702 | €644 | ▼ 8.2% |
| Recurring financial charges65 | €2k | €4k | €1k | €702 | €644 | ▼ 8.2% |
| Profit (loss) for the period before taxes9903 | €265k | €344k | €424k | €381k | €377k | ▼ 1.0% |
| Income taxes67/77 | €63k | €85k | €103k | €93k | €92k | ▼ 0.6% |
| Profit (loss) for the period9904 | €202k | €259k | €321k | €288k | €285k | ▼ 1.2% |
| Profit (loss) for the period to be appropriated9905 | €202k | €259k | €321k | €288k | €285k | ▼ 1.2% |
| Line | 2022 | 2023 | 2024 | 2025 | 2026 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €391k | €634k | €406k | €346k | €360k | ▲ 4.1% |
| Fixed assets21/28 | €13k | €61k | €46k | €31k | €89k | ▲ 191% |
| Tangible fixed assets22/27 | €13k | €61k | €46k | €31k | €89k | ▲ 191% |
| Land and buildings22 | - | - | - | - | €73k | - |
| Furniture and vehicles24 | €8k | €57k | €43k | €28k | €14k | ▼ 49.2% |
| Other tangible fixed assets26 | €5k | €4k | €3k | €3k | €2k | ▼ 16.7% |
| Current assets29/58 | €378k | €572k | €360k | €316k | €271k | ▼ 14.2% |
| Amounts receivable within one year40/41 | €100 | €0 | €17k | €0 | €9k | - |
| Trade receivables40 | €100 | €0 | - | - | - | - |
| Other amounts receivable41 | - | - | €17k | €0 | €9k | - |
| Current investments50/53 | €7k | €49k | €0 | - | - | - |
| Cash at bank and in hand54/58 | €226k | €371k | €122k | €148k | €68k | ▼ 54.0% |
| Deferred charges and accrued income490/1 | €145k | €152k | €221k | €168k | €193k | ▲ 15.5% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €391k | €634k | €406k | €346k | €360k | ▲ 4.1% |
| Equity10/15 | €326k | €106k | €6k | €6k | €6k | = |
| Contributions10/11 | €6k | €6k | €6k | €6k | €6k | = |
| Reserves13 | €320k | €100k | €0 | - | - | - |
| Distributable reserves133 | €320k | €100k | €0 | - | - | - |
| Profit (loss) carried forward14 | - | €0 | €0 | €0 | €0 | - |
| Amounts payable17/49 | €65k | €528k | €400k | €340k | €354k | ▲ 4.1% |
| Amounts payable after more than one year17 | - | €43k | €29k | €15k | €1k | ▼ 92.2% |
| Financial debts170/4 | - | €43k | €29k | €15k | €1k | ▼ 92.2% |
| Amounts payable within one year42/48 | €44k | €485k | €370k | €325k | €339k | ▲ 4.4% |
| Current portion of amounts payable after more than one year42 | - | €13k | €14k | €14k | €14k | ▲ 1.6% |
| Financial debts43 | - | - | €30 | €0 | - | - |
| Credit institutions430/8 | - | - | €30 | €0 | - | - |
| Trade debts44 | - | €3k | €192 | €2k | €26k | ▲ 1,325% |
| Suppliers440/4 | - | €3k | €192 | €2k | €26k | ▲ 1,325% |
| Taxes, remuneration and social security45 | €19k | €33k | €35k | €15k | €15k | ▼ 4.0% |
| Taxes450/3 | €17k | €33k | €35k | €15k | €15k | ▼ 4.0% |
| Remuneration and social security454/9 | €3k | €0 | - | - | - | - |
| Other amounts payable47/48 | €25k | €435k | €321k | €294k | €285k | ▼ 3.2% |
| Accrued charges and deferred income492/3 | €21k | €0 | - | - | €14k | - |
| Line | 2022 | 2023 | 2024 | 2025 | 2026 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €202k | €259k | €321k | €288k | €285k | ▼ 1.2% |
| + Depreciation and write-downs630 | €9k | €20k | €15k | €15k | €16k | ▲ 5.9% |
| Operating cash flow (approximation) | €211k | €279k | €337k | €303k | €301k | ▼ 0.8% |
| Investment in fixed assets (approximation) | - | €-69k | €0 | €0 | €-75k | - |
| Change in cash | - | €146k | €-249k | €26k | €-80k | ▼ 409% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2027, expected by
2026
09-06
NBB filing
Annual accounts filed
fiscal year 2026 · micro schema
2025
25-08
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2024
27-09
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
31-03
Financial
Highest result since 2020net €321k ▲24.2%
Operating result €423k, net result €321k, both a record.
2023
31-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2022
07-10
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
31-03
Financial
Equity above €200kEq €326k ▲164%
3 profitable years in a row build equity to €326k.
2021
28-09
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
31-03
Financial
Liquidity triplescurrent ratio 4.98
Current ratio from 1.83 to 4.98; short-term debt falls from €38k to €30k.
31-03
Financial
Equity above €100kEq €123k ▲170%
2 profitable years in a row build equity to €123k.
2020
07-10
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 2 acts read
About the unread acts
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Genk · 1 establishment unit since 2019
Ground area
4,239 m²
Building footprint
202 m²
Volume, LiDAR
1,874 m³
Parcel 71307H0034/00M219, Flanders · tallest building 15.3 m, ±3 floors. Linked by address, not a title deed.
2
companies at this address
See who is registered here
1 establishment unit
Dr. De Sutter Thomas
since 20192.297.493.894
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 71307H0034/00M219 | Flanders | 4,239 m² | 1 · 202 m² | 15.3 m · 3 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Docteur Bastien Decot Orthopédie
BE 0735.948.995
Hamois · Eq €6,000
FELIX MOTUS
BE 0745.458.658
Destelbergen · Eq €6,000
Barbara Deconinck, Endocrinologie-Diabetologie
BE 0754.795.008
Langemark-Poelkapelle · Eq €6,000
Dr. Van Nieuwenhove Saskia
BE 0761.583.622
Erpe-Mere · Eq €6,000
DR. L. KOLB, ANESTHESIST - ALGOLOOG
BE 0775.517.869
Zottegem · Eq €6,000
Of 16,625 companies in sector 86220 we hold annual accounts for 7,979. 1,601 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded05-12-2019
Fiscal year end31-03
Activities, NACEBEL 2025
86220Specialist medical practice
74999Other professional, scientific and technical activities
Scores and ratios are computed by Checked and are not a credit decision.